These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24819325)

  • 1. Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.
    Hayes MR; Mietlicki-Baase EG; Kanoski SE; De Jonghe BC
    Annu Rev Nutr; 2014; 34():237-60. PubMed ID: 24819325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretins, amylin and other gut-brain axis hormones in children with coeliac disease.
    Papastamataki M; Papassotiriou I; Bartzeliotou A; Vazeou A; Roma E; Chrousos GP; Kanaka-Gantenbein C
    Eur J Clin Invest; 2014 Jan; 44(1):74-82. PubMed ID: 24151959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic signals controlling food intake; insulin, glucagon and amylin.
    Woods SC; Lutz TA; Geary N; Langhans W
    Philos Trans R Soc Lond B Biol Sci; 2006 Jul; 361(1471):1219-35. PubMed ID: 16815800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology of incretins in health and disease.
    Deacon CF; Ahrén B
    Rev Diabet Stud; 2011; 8(3):293-306. PubMed ID: 22262068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GIP: no longer the neglected incretin twin?
    Kulkarni RN
    Sci Transl Med; 2010 Sep; 2(49):49ps47. PubMed ID: 20844284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incretin hormones: Their role in health and disease.
    Nauck MA; Meier JJ
    Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
    Opinto G; Natalicchio A; Marchetti P
    Arch Physiol Biochem; 2013 Oct; 119(4):170-8. PubMed ID: 23859800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New physiological effects of the incretin hormones GLP-1 and GIP.
    Asmar M
    Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic determinants of circulating GIP and GLP-1 concentrations.
    Almgren P; Lindqvist A; Krus U; Hakaste L; Ottosson-Laakso E; Asplund O; Sonestedt E; Prasad RB; Laurila E; Orho-Melander M; Melander O; Tuomi T; Holst JJ; Nilsson PM; Wierup N; Groop L; Ahlqvist E
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.
    Zarrinpar A; Loomba R
    Aliment Pharmacol Ther; 2012 Nov; 36(10):909-21. PubMed ID: 23057494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylin-mediated control of glycemia, energy balance, and cognition.
    Mietlicki-Baase EG
    Physiol Behav; 2016 Aug; 162():130-40. PubMed ID: 26922873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Glucagon-Like Peptide-1 in Energy Homeostasis.
    Salehi M; Purnell JQ
    Metab Syndr Relat Disord; 2019 May; 17(4):183-191. PubMed ID: 30720393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of gut hormones in appetite regulation (review).
    Marić G; Gazibara T; Zaletel I; Labudović Borović M; Tomanović N; Ćirić M; Puškaš N
    Acta Physiol Hung; 2014 Dec; 101(4):395-407. PubMed ID: 25532952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin.
    Wu T; Ma J; Bound MJ; Checklin H; Deacon CF; Jones KL; Horowitz M; Rayner CK
    Diabetes; 2014 Aug; 63(8):2776-87. PubMed ID: 24647737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.
    João AL; Reis F; Fernandes R
    Obes Rev; 2016 Jul; 17(7):553-72. PubMed ID: 27125902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of incretins on energy homeostasis: physiology and implications for the treatment of type 2 diabetes mellitus and obesity.
    Karras S; Goulis DG; Mintziori G; Katsiki N; Tzotzas T
    Curr Vasc Pharmacol; 2012 Nov; 10(6):781-91. PubMed ID: 22272906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
    Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
    Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.